Chengdu University of TCM
Chengdu, Sichuan, 610075, China
NCT Number: NCT00904592
1. Title: A Study on TCM comprehensive protocol of Prevention and Control in Diabetic Retinopathy. 2. Objectives of study: To evaluate the Intervention effect of integrate control protocol on reducing the incidence rate of proliferative diabetic retinopathy, PRP and MVL. Then produce a high performance, optimize, convenient, applicable and demonstrated protocol of integrate control with Intervention of TCM and west medicine. 3. Study Type: Interventional 4. Study Design: Multi-center, Randomized, Blind (Subject, Investigator, Outcomes Assessor), Parallel Assignment, Positive controlled clinical study. 5. Sample size: 480 subjects , divided into test and control groups equally. 6. Primary endpoint: incidence rate of proliferative diabetic retinopathy, panretinal photocoagulation
Looking for future studies?
Notify Me35 year–75 year
All sexes
Interventional
Not applicable
Chengdu, Sichuan, 610075, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Qi ming granula Usage:4.5g,po,tid. duration:12 months/ arise Endpoint Event
Other names: QM
Control group: Basic therapy & placebo
Other names: PC
Time frame: 12 months
Time frame: 12 weeks
Chengdu University of Traditional Chinese Medicine
Other
A Study on TCM Comprehensive Protocol of Prevention and Control in Diabetic Retinopathy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07707856
Cardiovascular Diseases, Diabetes Complications
Banhā, Benha, Egypt
View Trial DetailsNCT04132401
Age-Related Macular Degeneration, Cardiovascular Diseases
Manresa, Barcelona, Spain
View Trial DetailsNCT04505566
Cardiovascular Diseases, Diabetes Complications
Nashville, Tennessee, United States
View Trial DetailsNCT07255326
Autoimmune Diseases, Cardiovascular Diseases
Faisalabad, Punjab Province, Pakistan
View Trial Details